Heikki Joensuu

The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals. The focus of their research work is on clinical trials and their goals are to prove the effectiveness of BNCT treatment and to widen the treatments to tumors located in different areas of the body. They are especially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds.